WHOLE GENOME ANALYSIS BY ARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION IN PATIENTS WITH CONGENITAL MALFORMATIONS
Dimova I1, Vazharova R1, Nikolova D1, Tincheva R2, Nesheva D1, Uzunova Y3, Toncheva D1,*
*Corresponding Author: Professor Draga Toncheva, Department of Medical Genetics, Medical University Sofia, 2, Zdrave str., 1431 Sofia, Bulgaria; Tel./Fax: +359-2-952-0357; E-mail:dragatoncheva@yahoo.com
page: 33

MATERIALS AND METHODS

 

The study was approved by the Ethics Committee of the Medical University of Sofia, Sofia, Bulgaria. The parents of the children provided their informed consent. Peripheral blood was taken for genetic diagnostic testing. Chromosome Analysis. G-banded chromosomes were prepared from whole blood samples using standard laboratory protocol. DNA Extraction. DNA was extracted from blood samples by phenol-chloroform. The yield and purity for protein/RNA were estimated by a Nanodrop 1000 spectro photometer (Thermo Scientific, Wilmington, DE, USA). The DNA was checked on a 1% agarose gel: DNA of high molecular weight (>50 kb) indicated it was suitable for use. Genomic Arrays. We have used genomic array Cyto Chip (BlueGnome, Cambridge, Cambridgeshire, UK), cov ering the entire genome by bacterial artificial chromosome (BAC) clones at a median 565 kb, a resolution optimized to detect pathogenic imbalances while minimizing polymorphisms. In addition, sub-telomeric clones were included at a median 250 kb resolution, thus allowing reliable detection of mosaicism. The BAC clones of 90 known genetic conditions at a median 100 kb resolution were also included in the chip. This resulted in an average density of 1 clone/0.5 Mb. Probe Labeling, Hybridization, Image Capture and Data Analysis. Test- and sex-matched reference genomic DNA (400 ng) was labeled by random-priming, using a fluorescent labeling system (BlueGnome). The labeled products were puri- fied by AutoSeq™ G50 columns (Amersham Pharmacia Biotech Inc., Piscataway, NY, USA), and the incorporation of dyes was evaluated by the spectrophotometer (Nanodrop 1000, Thermo Scientific). Incorporation in the range of 6-15 pmol/µL and a DNA yield of 180-325 ng/µL were considered suitable for further analysis. A mix of Cy5- and Cy3- labeled probes and a mix of COT-1 and Herring sperm DNA were ethanol-precipitated at –80°C for at least 30 min. Hybridization was done using dissolved precipitated probes in a hybridization buffer.Arrays were washed in sodium chloride-sodium citrate (SSC) buffers with decreasing concentrations and scanned by a GenPix 4100A (Axon Instruments, Union City, CA, USA). The images were analyzed by BlueFuse for Microarrays 3.5 software (BlueGnome). In data processing log2 ratios of Cy3 and Cy5, intensities were generated for all hybridized clones. Normal copy numbers were considered to be present if the log2 ratio was between –0.3 and +0.3, values above +0.3 were interpreted as gain/ amplification and those under –0.3 as losses (deletions). Genomic profiles were represented plotting log2 ratios in Y-axis and the 23 chromosomes in Xaxis. Individual chromosomal profiles were represented with clone positions in Y-axis and log2 ratios in X-axis.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006